lobbying_activities: 2427208

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2427208	005221bd-0642-4a66-b0f5-42ff6b48d430	Q1	MEHLMAN CONSULTING, INC.	284950	ASSOCIATION OF ACCESSIBLE MEDICINES	2020	first_quarter	PHA	Medicaid and Medicare drug pricing. Prescription drug pricing. H.R. 965 - CREATES Act of 2019. H.R. 985 - FAST Generics Act of 2019. S.1895 - Lower Health Care Costs Act. S. 440 - PACED Act H.R. 938 - BLOCKING Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act of 2019	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2020-04-15T21:40:09.347000-04:00